标题
68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients
作者
关键词
-
出版物
CLINICAL NUCLEAR MEDICINE
Volume Publish Ahead of Print, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-02-02
DOI
10.1097/rlu.0000000000004523
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
- (2021) Halil Kömek et al. ANNALS OF NUCLEAR MEDICINE
- Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer
- (2021) Rong Lin et al. CLINICAL NUCLEAR MEDICINE
- Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
- (2020) Haojun Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
- (2020) Haojun Chen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- [68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis
- (2020) Tingting Xu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Molecular Classification of Breast Cancer
- (2019) Julia Y.S. Tsang et al. ADVANCES IN ANATOMIC PATHOLOGY
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical evaluation of a dual sstr2 and integrin αvβ3-targeted heterodimer [68Ga]-NOTA-3PEG4-TATE-RGD
- (2019) Bingnan Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
- (2018) Ellen Puré et al. ONCOGENE
- FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers
- (2018) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma
- (2016) Cheol Keun Park et al. BREAST CANCER RESEARCH AND TREATMENT
- Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer
- (2015) Sung Yeon Park et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of cancer-associated fibroblast-related proteins in adipose stroma of breast cancer
- (2015) Yoon Yang Jung et al. TUMOR BIOLOGY
- Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis
- (2015) Fang Liu et al. PLoS One
- Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
- (2014) Elizabeth J. Hamson et al. Proteomics Clinical Applications
- [18F]Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Breast Cancer: When… and When Not?
- (2012) David A. Mankoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study of 2-[18F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study
- (2012) Kathleen I. Pritchard et al. JOURNAL OF CLINICAL ONCOLOGY
- The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature
- (2010) Rebecca Peare et al. BREAST CANCER RESEARCH AND TREATMENT
- Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
- (2009) Till A. Heusner et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started